SCRI Oncology Partners ( Site 7000) — Nashville, Tennessee

SCRI Oncology Partners ( Site 7000) is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 66/100 (FAIR). This profile has not yet been claimed by the site owner.

SCRI Oncology Partners ( Site 7000) has participated in 5 clinical trials with 5 currently active.

Therapeutic areas: Triple-Negative Breast Cancer, Breast Neoplasms, Prostate Cancer Metastatic.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 66/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for SCRI Oncology Partners ( Site 7000)?

SCRI Oncology Partners ( Site 7000) has a Crixeo Trust Score of 66/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has SCRI Oncology Partners ( Site 7000) conducted?

SCRI Oncology Partners ( Site 7000) has 5 clinical trials on record, with 5 currently active. Their work covers Triple-Negative Breast Cancer, Breast Neoplasms, Prostate Cancer Metastatic.

Is SCRI Oncology Partners ( Site 7000) accredited by Crixeo Health?

SCRI Oncology Partners ( Site 7000) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about SCRI Oncology Partners ( Site 7000)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.